Latest filing published 18 Sept 2025 for Pulse Biosciences, INC., €84k.
Filing timeline
BuySaleInsider track record
Darrin Uecker: trading record in brief
Darrin Uecker, listed as senior executive, appears in our data through filings on Pulse Biosciences, Inc. shares, published by SEC (Form 4). In total, 6 filings cover trades dated from 9 June 2022 to 16 September 2025.
The open-market record consists of 1 sale worth €212k, with no purchase. Besides market trades, the filings include 3 share grants and 2 option exercises. Since January 2025: no purchases and 1 sale on the market.
The newest entry dates from 18 September 2025: an option exercise of €84k, in Pulse Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Darrin Uecker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$4.0021.3% of flowCommon StockSEC:0001437749-25-029432:0
- 25,000 shares@ US$4.0021.5% of flowCommon StockSEC:0001437749-25-029104:0
- 15,000 shares@ US$16.400.0076% mcap53.6% of flowCommon StockSEC:0001437749-25-020563:0
- 7,365 shares@ US$2.053.5% of flowCommon StockSEC:0001437749-23-017295:0
- 7,365 sharesCommon StockSEC:0001387131-22-006921:0
5 of 5 declarations
